Cadinha & Co. LLC Invests $759,000 in iShares NASDAQ Biotechnology Index (IBB)

Cadinha & Co. LLC purchased a new stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 7,110 shares of the financial services provider’s stock, valued at approximately $759,000.

A number of other hedge funds have also modified their holdings of the business. Crestwood Advisors Group LLC raised its holdings in shares of iShares NASDAQ Biotechnology Index by 1.6% in the 3rd quarter. Crestwood Advisors Group LLC now owns 69,893 shares of the financial services provider’s stock valued at $23,316,000 after purchasing an additional 1,107 shares in the last quarter. Atlantic Trust Group LLC raised its holdings in shares of iShares NASDAQ Biotechnology Index by 12.4% in the 3rd quarter. Atlantic Trust Group LLC now owns 20,642 shares of the financial services provider’s stock valued at $6,887,000 after purchasing an additional 2,280 shares in the last quarter. Mathes Company Inc. raised its holdings in shares of iShares NASDAQ Biotechnology Index by 190.4% in the 4th quarter. Mathes Company Inc. now owns 13,605 shares of the financial services provider’s stock valued at $1,453,000 after purchasing an additional 8,920 shares in the last quarter. Burns J W & Co. Inc. NY raised its holdings in shares of iShares NASDAQ Biotechnology Index by 187.2% in the 4th quarter. Burns J W & Co. Inc. NY now owns 27,073 shares of the financial services provider’s stock valued at $2,891,000 after purchasing an additional 17,647 shares in the last quarter. Finally, Private Capital Advisors Inc. raised its holdings in shares of iShares NASDAQ Biotechnology Index by 973.1% in the 4th quarter. Private Capital Advisors Inc. now owns 19,433 shares of the financial services provider’s stock valued at $2,075,000 after purchasing an additional 17,622 shares in the last quarter. 27.28% of the stock is owned by institutional investors.

Shares of iShares NASDAQ Biotechnology Index (NASDAQ IBB) opened at $107.35 on Tuesday. iShares NASDAQ Biotechnology Index has a fifty-two week low of $94.20 and a fifty-two week high of $119.30. The firm has a market cap of $9,470.00, a price-to-earnings ratio of 3.55 and a beta of 1.37.

ILLEGAL ACTIVITY NOTICE: “Cadinha & Co. LLC Invests $759,000 in iShares NASDAQ Biotechnology Index (IBB)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/13/cadinha-co-llc-buys-new-position-in-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply